Market Capitalization & Enterprise Value
Research-grade valuation history for URAL. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.
Market Cap & Enterprise Value
Comparison of market capitalization and enterprise value over time
Market Cap
Enterprise Value
Market Cap History
Investor Valuation Insights
As of Sep 30, 2021EV/EBITDA
13.12x
This is a common valuation range; compare to peers and growth outlook before concluding.
EV vs Market Cap Spread
1.23M
EV is +27.3% vs equity value
Capital Structure Signal
Net Debt Profile
Trend unavailable for selected history
Additional Multiples
EV/Sales: 2.72x
Net Debt/EBITDA: 12.48x
Share count trend unavailable
Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.
Market Cap & Enterprise Value Data
Free users can view the latest 3 records. Upgrade to see full history.
| Date | Market Cap | Enterprise Value | Stock Price | Shares |
|---|---|---|---|---|
| Mar 31, 2021 | 4.50M | 5.73M | $3.78 | 1.19M |
| Mar 31, 2020 | 5.01M | 5.79M | $14.80 | 338.42K |
| Mar 31, 2019 | 5.67M | 6.51M | $98.00 | 57.81K |
Mar 31, 2018 | — | — | — | — |
Mar 31, 2017 | — | — | — | — |
Mar 31, 2016 | — | — | — | — |
Mar 31, 2015 | — | — | — | — |
Mar 31, 2014 | — | — | — | — |
Mar 31, 2013 | — | — | — | — |